Switch to:
More From Other Websites
Acasti Announces First Quarter Results Jul 15 2014
Neptune Announces First Quarter Results Jul 15 2014
Acasti Completes Phase II Double Blind (TRIFECTA) and Pharmacokinetic Trials Jul 09 2014
Neptune to Hold Conference Call to Discuss First Quarter Results Jul 08 2014
Neptune Receives Composition Patent in Australia Jun 23 2014
NeuroBioPharm Reports Results of Annual General Meeting Jun 20 2014
Neptune Reports Results of Annual and Special Meeting Jun 20 2014
Neptune Sherbrooke Plant to Resume Production Jun 13 2014
Has Enzymotec Been Over-Punished? Jun 09 2014
NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Financials Jun 06 2014
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive Officer May 30 2014
High option volume stocks May 28 2014
Neptune Technologies appoints Andre Godin as interim CEO May 23 2014
Neptune, Acasti and NeuroBioPharm Announce Appointment of Interim CEO May 23 2014
Neptune Technologies reports Q4 revenue $3.67M, consensus $7.08M May 21 2014
Neptune Announces Fourth Quarter and Fiscal Year Results May 21 2014
NeuroBioPharm Announces Resignation of Chief Financial Officer May 20 2014
Neptune Announces Proposed Director Nominees for Its Upcoming Annual General Meeting May 16 2014
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year Results May 13 2014
Neptune Technologies says CSST report attributes some responsibility to company May 08 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide